[vc_row][vc_column width=”1/2″][vc_single_image image=”10329″ img_size=”medium” alignment=”center”][/vc_column][vc_column width=”1/2″][vc_single_image image=”10328″ img_size=”medium” alignment=”center”][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space][vc_column_text]In our October All-Member Webinar, TpAML co-founder/advocate Julie Guillot and Dr. Gwen Nichols, Chief Medical Officer, Leukemia & Lymphoma Society, highlighted the energy and work behind putting — and keeping — the patient at the center of drug development.

[/vc_column_text][vc_empty_space][/vc_column][vc_column][/vc_column][/vc_row][vc_row][vc_column][vc_video link=”https://youtu.be/RfsjaRcm_Ug” align=”center”][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]